A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors.Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets lost in cancer cells, potentially creating breakthrough therapies to treat most cancers.
We are an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. Read more here: